Studies in males with deleterious TLR7 variants support this sex-based vulnerability to COVID-19, suggesting that the TLR7 gene-dose effect renders males more susceptible to severe outcomes [29,30,31,32]. This evidence concerns the gene TLR7 and COVID-19.